Edit |   |
---|---|
Antigenic Specificity | APP, Human (Crenezumab biosimilar) |
Clone | Crenezumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human APP Recombinant Antibody (Crenezumab). Crenezumab is a fully humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease. Crenezumab is highly homologous to solanezumab, another monoclonal antibody targeting amyloid- peptides. |
Immunogen | n/a |
Other Names | Anti-APP Recombinant Antibody, Research Grade Crenezumab, Anti-Human APP Recombinant Antibody(Crenezumab), MABT5102A, RG7412, Antibody Drug Analogues, Monoclonal Antibody, YR1256, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1095207-05-8 |
Catalog # | YR1256 |
Price | please inquire |
Order / More Info | APP, Human (Crenezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |